The clinical trial documents describe a study in which CRISPR is employed to modify human embryos before they are transferred into women’s uteruses. The scientist behind the effort, He Jiankui, did not reply to a list of questions about whether the undertaking had produced a live birth. Reached by telephone, he declined to comment. However, data submitted as part of the trial listing shows that ge